Skip to main content
European Commission logo

International cooperation

New-generation power semiconductors, made in Europe

An EU, industry, national and regional-funded research project has developed the next generation of energy-efficient power semiconductors, using gallium nitride devices on innovative substrates. They can switch more quickly at high voltages and current densities and will power the smaller and cheaper energy-efficient applications of tomorrow.

Add to pdf basket

Firm ground for platform advancing offshore renewable energy

Wind, wave, tidal - there is plenty of energy to harvest at sea, and plenty of room for innovation to tap this potential for greater sustainability contributing to a key sector in the European Commission's Green Deal. Test sites from several countries have joined forces to strengthen Europe's position at the forefront of this area of R&D. An EU-funded project has taken their cooperation a step further.

Add to pdf basket

Home improvements for the planet

Renovating energy-inefficient buildings is crucial if Europe is to reduce its carbon footprint. That is why an EU-funded project is making renovations faster and easier, helping homes to save energy - for the benefit of the general public and the planet.

Add to pdf basket

Strengthening European food research

The food industry will face significant challenges in the future. However, an EU-funded project has created an international research network capable of confronting environmental threats as well as consumer demand for traceable, ethical ingredients.

Add to pdf basket

A solution to the problem of space junk

The intensification of human-driven activity in space over the past 60 years has led to a proliferation of debris orbiting the Earth. An EU-funded project is pioneering new technology that can clean up this problematic space junk.

Add to pdf basket

Replacing an enzyme to control a very rare disease

Until recently, there was no treatment specific to alpha-mannosidosis, one of the many rare diseases that jointly affect some 30 million citizens in Europe alone. Today, there is as EU-funded research developed enzyme-replacement therapy to stop the illness in its tracks, and this medicine is on the market.

Add to pdf basket